Stock 1801 INNOVENT BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Innovent Biologics, Inc.

Equities

1801

KYG4818G1010

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:22 10/05/2024 BST 		5-day change 1st Jan Change
41.4 HKD +2.10% Intraday chart for Innovent Biologics, Inc. -1.08% -3.16%
05-07 Innovent Receives NMPA Breakthrough Therapy Designation for IBI343(Anti-Claudin18.2 ADC) as Monotherapy for Advanced Gastric Cancer CI
04-30 Innovent Biologics, Inc. Reports Revenue Results for the First Quarter of 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
 8.62B -
CSL LIMITED Stock CSL Limited
 89.08B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 40.9B
BIOGEN INC. Stock Biogen Inc.
 32.25B
UCB Stock UCB
 25.14B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 15.39B
  1. Stock Market
  2. Equities
  3. 1801 Stock
  4. Charts Innovent Biologics, Inc.
  5. Sector Chart